Raymond James Financial Inc. Makes New $285,000 Investment in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)
Raymond James Financial Inc. acquired a new position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) during the 4th quarter, HoldingsChannel.com reports. The firm acquired 22,645 shares of the biotechnology company’s stock, valued at approximately $285,000. Several other large investors have also recently bought and sold shares of the company. SG Americas Securities […]
